Synergistic antitumor effect of c-Met-dependent oncolytic adenovirus combined with rapamycin in non-small cell lung cancer
碩士 === 國立成功大學 === 微生物及免疫學研究所 === 96 === Lung cancer is a deadly disease with high mortality and morbidity. Approximately 85% of these cases are non-small cell lung cancer (NSCLC) with the rest being small cell lung cancer (SCLC). Like normal cells, lung cancer cells express receptor tyrosine kinases...
Main Authors: | Jeng-Liang Tsai, 蔡政良 |
---|---|
Other Authors: | Al-Li Shiau |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/09451060211457183819 |
Similar Items
-
Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine against Retinoblastoma Cells
by: Xianqun Fan, et al.
Published: (2012-08-01) -
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
by: Coffey Matthew C, et al.
Published: (2009-07-01) -
Chemovirotherapy of Lung Squamous Cell Carcinoma by Combining Oncolytic Adenovirus With Gemcitabine
by: Xing Liu, et al.
Published: (2020-02-01) -
Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor
by: Sakr HI, et al.
Published: (2015-09-01) -
Combining IL-10 and Oncolytic Adenovirus Demonstrates Enhanced Antitumor Efficacy Through CD8+ T Cells
by: Duo Chen, et al.
Published: (2021-02-01)